JMP Securities Maintains Market Outperform on LeMaitre Vascular, Raises Price Target to $100
Portfolio Pulse from Benzinga Newsdesk
JMP Securities has maintained a Market Outperform rating on LeMaitre Vascular and raised its price target from $77 to $100, indicating confidence in the company's future performance.
August 20, 2024 | 11:57 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JMP Securities has increased its price target for LeMaitre Vascular from $77 to $100, while maintaining a Market Outperform rating. This suggests a positive outlook for the company's stock.
The increase in price target from $77 to $100 by JMP Securities, along with the maintained Market Outperform rating, indicates strong confidence in LeMaitre Vascular's future performance. This is likely to positively influence investor sentiment and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100